Ajinomoto CELLiST Korea, a specialised company in cell culture media, recently announced the opening of CELLiST Centre India (CSC) in Ahmedabad, India.
The CSC is a customer solution centre which offers technical support to global biopharmaceuticals. By accelerating the development and maximizing productivity, these centres are developed to support customers. These centres are located in South Korea, China and India. CSC India provides technical support services including cell adaptation and media screening, scale-up support, protein quality analysis and media customisation.
Commenting on the CSC centre, Masakazu Sugiyama, President of Ajinomoto CELLiST Korea, said, "With the rapid growth in demand for cell culture media in India, we have opened CSC India to meet these needs and provide customized technical support. Through this initiative, we plan to supply high-quality, tailored cell culture media to more biopharmaceutical manufacturers globally."
Ajinomoto CELLiST Korea, established a media production facility in South Korea's Incheon in 2014. This facility manufactures cell culture media for CHO and HEK293 cell lines.
"As part of the 2030 Roadmap, we have identified the cell culture media business for biopharmaceuticals as a core focus of Healthcare domain. We plan to further strengthen our global supply chain for amino acids, which are key raw materials in bioprocess technology and cell culture media, leveraging our over 30 years of experience in the pharmaceutical and food amino acid business" said, an official from Ajinomoto group.